227 related articles for article (PubMed ID: 18302674)
1. ESE-1 inhibits the invasion of oral squamous cell carcinoma in conjunction with MMP-9 suppression.
Iwai S; Amekawa S; Yomogida K; Sumi T; Nakazawa M; Yura Y; Nishimune Y; Nozaki M
Oral Dis; 2008 Mar; 14(2):144-9. PubMed ID: 18302674
[TBL] [Abstract][Full Text] [Related]
2. Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines.
Shindoh M; Higashino F; Kaya M; Yasuda M; Funaoka K; Hanzawa M; Hida K; Kohgo T; Amemiya A; Yoshida K; Fujinaga K
Am J Pathol; 1996 Mar; 148(3):693-700. PubMed ID: 8774124
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes.
Hanzawa M; Shindoh M; Higashino F; Yasuda M; Inoue N; Hida K; Ono M; Kohgo T; Nakamura M; Notani K; Fukuda H; Totsuka Y; Yoshida K; Fujinaga K
Carcinogenesis; 2000 Jun; 21(6):1079-85. PubMed ID: 10836994
[TBL] [Abstract][Full Text] [Related]
5. E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters.
Izumiyama Y; Ohiro Y; Higashino F; Yoshida K; Taguchi K; Todo S; Kohgo T; Totsuka Y; Shindoh M
Oncol Rep; 2005 Apr; 13(4):715-20. PubMed ID: 15756447
[TBL] [Abstract][Full Text] [Related]
6. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
Fang LY; Wong TY; Chiang WF; Chen YL
J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021
[TBL] [Abstract][Full Text] [Related]
7. Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.
Hida K; Shindoh M; Yasuda M; Hanzawa M; Funaoka K; Kohgo T; Amemiya A; Totsuka Y; Yoshida K; Fujinaga K
Am J Pathol; 1997 Jun; 150(6):2125-32. PubMed ID: 9176403
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer.
Sharwani A; Jerjes W; Hopper C; Lewis MP; El-Maaytah M; Khalil HS; Macrobert AJ; Upile T; Salih V
Arch Oral Biol; 2006 Dec; 51(12):1104-11. PubMed ID: 16889746
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.
Ito H; Duxbury M; Benoit E; Clancy TE; Zinner MJ; Ashley SW; Whang EE
Cancer Res; 2004 Oct; 64(20):7439-46. PubMed ID: 15492268
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L
Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
13. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
Bindhu OS; Ramadas K; Sebastian P; Pillai MR
Head Neck; 2006 Oct; 28(10):916-25. PubMed ID: 16823875
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo.
Ala-aho R; Ahonen M; George SJ; Heikkilä J; Grénman R; Kallajoki M; Kähäri VM
Oncogene; 2004 Jul; 23(30):5111-23. PubMed ID: 15094779
[TBL] [Abstract][Full Text] [Related]
15. The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer.
Behrens P; Rothe M; Wellmann A; Krischler J; Wernert N
J Pathol; 2001 May; 194(1):43-50. PubMed ID: 11329140
[TBL] [Abstract][Full Text] [Related]
16. nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression.
Khan MH; Yasuda M; Higashino F; Haque S; Kohgo T; Nakamura M; Shindoh M
Am J Pathol; 2001 May; 158(5):1785-91. PubMed ID: 11337376
[TBL] [Abstract][Full Text] [Related]
17. Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.
Horváth B; Hegyesi H; Nagy P; Falus A; Schaff Z
Head Neck; 2005 Jul; 27(7):585-96. PubMed ID: 15887216
[TBL] [Abstract][Full Text] [Related]
18. Basaloid squamous carcinoma of the oral cavity: report of 2 cases and study of AgNOR, PCNA, p53, and MMP expression.
Coletta RD; Cotrim P; Vargas PA; Villalba H; Pires FR; de Moraes M; de Almeida OP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):563-9. PubMed ID: 11346736
[TBL] [Abstract][Full Text] [Related]
19. S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9.
Sapkota D; Bruland O; Costea DE; Haugen H; Vasstrand EN; Ibrahim SO
Eur J Cancer; 2011 Mar; 47(4):600-10. PubMed ID: 21074410
[TBL] [Abstract][Full Text] [Related]
20. Role of matrix metalloproteinase-9 in in vitro invasion of esophageal carcinoma cells.
Suzuki T; Kuwabara Y; Iwata H; Mitani M; Shinoda N; Sato A; Mitsui A; Sugiura M; Kato J; Fujii Y
J Surg Oncol; 2002 Oct; 81(2):80-6. PubMed ID: 12355408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
